Category: Healthcare
-
Date:
Congestive Heart Failure Drugs Market to Surpass US$ 13.5 Billion by 2031 Driven by Rising Cardiovascular Disease Burden and Advancements in Heart Failure Therapies
The global congestive heart failure (CHF) drugs market is witnessing significant growth, supported by the increasing prevalence of cardiovascular diseases and growing…
-
Date:
Lipid-lowering Drugs Market to Surpass USD 42.5 Billion by 2031, Driven by Rising Cardiovascular Disease Burden | TMR
Lipid-lowering Drugs Market Overview Lipid-lowering drugs are medications used to reduce cholesterol and other lipid levels in the blood, thereby lowering the…
-
Date:
Global RAS-acting Agents Market to Surpass USD 13.4 Bn by 2031 Amid Strategic Advances by AstraZeneca and Boehringer Ingelheim
The global RAS-acting Agents Market was valued at USD 9.7 billion in 2022 and is projected to surpass USD 13.4 billion by…
-
Date:
Vasopressin Antagonists Market to Reach USD 2.7 Billion by 2031 Amid Rising Demand for Fluid Management Therapies
The global Vasopressin Antagonists Market is experiencing significant growth due to the rising prevalence of hyponatremia, heart failure, liver cirrhosis, and kidney-related…
-
Date:
Global Mesenchymal Stem Cells Market Set to Surpass USD 10.1 Bn by 2031 Amid Rising Demand for Regenerative Therapies
The global Regenerative Medicine industry is witnessing rapid transformation, with mesenchymal stem cells (MSCs) emerging as one of the most promising therapeutic…
-
Date:
Diuretic Drugs Market Size Forecast to USD 157.2 Million by 2031 with Rising Demand for Hypertension and Cardiovascular Treatments – Analysis by Transparency Market Research
The global diuretic drugs market is witnessing steady growth, supported by the increasing prevalence of hypertension, cardiovascular diseases, and kidney-related disorders worldwide.…
-
Date:
Peripheral Vasodilator Drugs Market Set to Surpass USD 9 Billion by 2031 Amid Rising Cardiovascular Burden and Innovation in Drug Development
The global peripheral vasodilator drugs market was valued at US$ 6.0 billion in 2022 and is projected to reach over US$ 9.0…
-
Date:
Global Radiopharmaceutical Theranostics Market Forecast 2031: Lutetium-177 Innovation, Precision Oncology, and Rising Cancer Burden to Drive Market Beyond USD 12.4 Billion
The global radiopharmaceutical theranostics market was valued at US$ 3.0 Bn in 2022 and is projected to surpass US$ 12.4 Bn by…
-
Date:
Global Antihyperlipidemic Drugs Market to Hit USD 20.1 Bn by 2031, Led by Pfizer, AstraZeneca, and Novartis
The global antihyperlipidemic drugs market is poised for steady growth, driven by the rising prevalence of cardiovascular diseases, increasing awareness of cholesterol…
-
Date:
Cardio-Selective Beta Blockers Market to Exceed US$ 10.1 Billion by 2031, Driven by Rising Cardiovascular Disease Burden and Aging Population
Cardio-selective Beta Blockers Market Overview Cardio-selective beta blockers, also known as beta-1 selective blockers, are a class of drugs designed to specifically…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.
